Pliant Therapeutics (PLRX) Operating Margin (2020 - 2023)
Pliant Therapeutics (PLRX) reported Operating Margin of 19083.87% for Q2 2023, down 1848972.0% year-over-year from N/an in Q2 2022, and down 503.87% quarter-over-quarter from 3160.29% in Q1 2023.
Pliant Therapeutics (PLRX) Operating Margin (2020 - 2023) Analysis & Trends
Pliant Therapeutics (PLRX) has 4 years of Operating Margin data on file, last reported at 19083.87% in Q2 2023.
- Operating Margin for Q2 2023 came in at 19083.87%, down 1848972.0% year-over-year; the trailing twelve-month figure through Mar 2024 was 78404.03% (down 7695968.0% YoY), and the FY2023 annual result was 11654.75%, down 1034138.0% from the prior year.
- Operating Margin retreated to 19083.87% in Q2 2023 per PLRX's latest filing, from 3160.29% in the prior quarter.
- Over five years, Operating Margin peaked at 38.04% in Q1 2020 and troughed at 19083.87% in Q2 2023.
- A 4-year average of 2543.61% and a median of 1255.42% in 2021 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2022 and 2023: Operating Margin soared 68612 bps in 2022, then tumbled 1848972 bps in 2023.
- A 4-year view of Operating Margin shows it stood at 425.89% in 2020, then plunged by 189 bps to 1230.57% in 2021, then slumped by 55 bps to 1903.31% in 2022, then plunged by 903 bps to 19083.87% in 2023.
- Business Quant data shows PLRX's Operating Margin at 19083.87% in Q2 2023, 3160.29% in Q1 2023, and 1903.31% in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -19,083.87% |
| Mar 31, 2023 | -3,160.29% |
| Dec 31, 2022 | -1,903.31% |
| Sep 30, 2022 | -2,155.67% |
| Jun 30, 2022 | -594.15% |
| Mar 31, 2022 | -2,258.69% |
| Dec 31, 2021 | -1,230.57% |
| Sep 30, 2021 | -1,684.04% |
| Jun 30, 2021 | -1,280.27% |
| Mar 31, 2021 | -1,054.23% |
| Dec 31, 2020 | -425.89% |
| Sep 30, 2020 | -346.09% |
| Jun 30, 2020 | -471.56% |
| Mar 31, 2020 | 38.04% |